Nephros Historical Income Statement
| NEPH Stock | USD 1.52 0.04 2.56% |
Historical analysis of Nephros income statement accounts such as Gross Profit of 10.1 M can show how well Nephros performed in making a profits. Evaluating Nephros income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Nephros's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Nephros latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nephros is a good buy for the upcoming year.
Nephros |
About Nephros Income Statement Analysis
Nephros Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Nephros shareholders. The income statement also shows Nephros investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Nephros Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Nephros generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Nephros minus its cost of goods sold. It is profit before Nephros operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Nephros. It is also known as Nephros overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Nephros' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Nephros current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.As of now, Nephros' Research Development is increasing as compared to previous years. The Nephros' current Cost Of Revenue is estimated to increase to about 7 M, while Depreciation And Amortization is projected to decrease to under 183 K.
| 2022 | 2023 | 2024 | 2025 (projected) | Gross Profit | 4.7M | 8.4M | 9.7M | 10.1M | Total Revenue | 10.0M | 14.2M | 16.4M | 17.2M |
Nephros income statement Correlations
Click cells to compare fundamentals
Nephros Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nephros income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 479K | 513K | 571K | 214K | 192.6K | 183.0K | |
| Interest Expense | 110K | 41K | 20K | 2K | 1.8K | 1.7K | |
| Total Revenue | 8.6M | 10.4M | 10.0M | 14.2M | 16.4M | 17.2M | |
| Gross Profit | 4.9M | 5.7M | 4.7M | 8.4M | 9.7M | 10.1M | |
| Other Operating Expenses | 13.1M | 14.7M | 14.3M | 15.8M | 18.2M | 19.1M | |
| Operating Income | (3.3M) | (4.5M) | (4.3M) | (1.6M) | (1.8M) | (1.9M) | |
| Ebit | (4.4M) | (2.7M) | (4.5M) | (1.6M) | (1.8M) | (1.9M) | |
| Research Development | 2.8M | 2.2M | 1.3M | 873K | 1.0M | 1.5M | |
| Ebitda | (3.9M) | (2.2M) | (3.9M) | (1.4M) | (1.6M) | (1.6M) | |
| Cost Of Revenue | 3.6M | 4.7M | 5.2M | 5.8M | 6.7M | 7.0M | |
| Total Operating Expenses | 9.4M | 10.1M | 9.1M | 10.0M | 11.5M | 6.5M | |
| Net Income | (4.7M) | (4.2M) | (7.3M) | (1.6M) | (1.8M) | (1.9M) | |
| Income Tax Expense | 198K | 298K | 3.0M | 46.1K | 41.5K | 39.4K | |
| Selling General Administrative | 6.5M | 7.7M | 7.6M | 8.3M | 9.5M | 5.1M | |
| Income Before Tax | (4.5M) | (3.9M) | (4.3M) | (1.6M) | (1.8M) | (1.9M) | |
| Total Other Income Expense Net | (22K) | 468K | 58K | 18K | 16.2K | 17.0K | |
| Net Income From Continuing Ops | (4.8M) | (3.9M) | (4.3M) | (1.6M) | (1.5M) | (1.5M) | |
| Net Income Applicable To Common Shares | (3.4M) | (4.8M) | (4.1M) | (7.4M) | (6.6M) | (6.3M) | |
| Interest Income | 11K | 10K | 14K | 43K | 38.7K | 36.8K | |
| Minority Interest | 3.1M | (240K) | (276K) | (70K) | (63K) | (59.9K) | |
| Net Interest Income | (99K) | (31K) | (6K) | 39K | 44.9K | 47.1K | |
| Reconciled Depreciation | 163K | 200K | 208K | 202K | 250.7K | 224.2K |
Currently Active Assets on Macroaxis
When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Household Appliances space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets | Return On Equity |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.